Peer-reviewedCC BY 4.0iScience
Targeting host ferroptosis in cancer cachexia: Tumor-immune triggers, tissue wasting, and the therapeutic paradox
Related
- Targeting asparagine synthetase triggers ferroptosis and suppresses endometrial cancer growth via Atractylenolide II
- Behavioral dysfunction but not wasting in cancer cachexia is driven by altered tryptophan metabolism
- Nano-formulations in therapeutic strategies targeting cancer ferroptosis
- Targeting Ferroptosis in Neurodegenerative Diseases: Therapeutic Potential and Mechanistic Insights of Traditional Chinese Medicine.
- Mitochondria-associated ferroptosis in ischemic stroke: Pathophysiological evolution, interorganelle crosstalk, and therapeutic targeting
BibTeX
@article{li2026targeting,
title = {{Targeting host ferroptosis in cancer cachexia: Tumor-immune triggers, tissue wasting, and the therapeutic paradox}},
author = {Yan Li and Rui Chen and Shengguang Ding},
journal = {iScience},
year = {2026},
month = oct,
doi = {10.1016/j.isci.2026.117764},
url = {https://www.cell.com/iscience/fulltext/S2589-0042(26)03145-7},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Targeting host ferroptosis in cancer cachexia: Tumor-immune triggers, tissue wasting, and the therapeutic paradox
AU - Yan Li
AU - Rui Chen
AU - Shengguang Ding
PY - 2026
DA - 2026/10/05
JO - iScience
DO - 10.1016/j.isci.2026.117764
UR - https://www.cell.com/iscience/fulltext/S2589-0042(26)03145-7
SN - 2589-0042
ER -